PVA Removal from Official List - Monday, 7 May 2018 |
04/05/18 | | 221.8KB | Share |
|
PVA Suspension from Official Quotation |
30/04/18 | PRICE SENSITIVE | 222.09KB | Share |
|
PVA Preliminary Proxy |
30/04/18 | | 297.74KB | Share |
|
PVA Reinstatement to Official Quotation |
26/04/18 | PRICE SENSITIVE | 221.52KB | Share |
|
PVA Response to ASX Price and Volume Query |
26/04/18 | PRICE SENSITIVE | 985.68KB | Share |
|
PVA Suspension from Official Quotation |
26/04/18 | PRICE SENSITIVE | 221.46KB | Share |
|
PVA EyePoint Patent Allowance |
13/04/18 | PRICE SENSITIVE | 144.76KB | Share |
|
PVA Approval to Delist |
04/04/18 | | 576.29KB | Share |
|
PVA Form 8-K |
03/04/18 | | 66.07KB | Share |
|
PVA ASX Delisting |
29/03/18 | | 116.89KB | Share |
|
PVA pSivida Announces Acquisition of Icon |
29/03/18 | PRICE SENSITIVE | 168.11KB | Share |
|
PVA Nancy Lerker Form 4 |
22/03/18 | | 100.83KB | Share |
|
PVA Len Ross Form 4 |
22/03/18 | | 97.9KB | Share |
|
PVA Dario Paggiarino Form 4 |
22/03/18 | | 135.42KB | Share |
|
PVA Deb Jorn Resignation |
22/03/18 | | 33.54KB | Share |
|
PVA pSivida Announces FDA Acceptance For Filing of New Drug Appl |
20/03/18 | PRICE SENSITIVE | 66.22KB | Share |
|
PVA Appendix 3B |
20/03/18 | | 824.28KB | Share |
|
PVA pSivida Corp Dec 2017 Form 10-Q |
09/02/18 | PRICE SENSITIVE | 634.37KB | Share |
|
PVA Form 8-K Earnings Release for Q2 FY 2018 |
09/02/18 | PRICE SENSITIVE | 72.28KB | Share |
|
PVA Appendix 3B - January 2018 |
02/02/18 | | 375.33KB | Share |
|
PVA Corporate Governance Report - January 2018 |
30/01/18 | | 325.71KB | Share |
|
PVA Appendix 4G - January 2018 |
30/01/18 | | 474.68KB | Share |
|
PVA pSivida Submits New Drug Application (NDA) for Durasert |
10/01/18 | PRICE SENSITIVE | 316.47KB | Share |
|
PVA Appendix 3B - December 2017 |
10/01/18 | | 369.42KB | Share |
|
PVA pSivida Granted Waiver by the FDA for NDA Fee |
05/01/18 | PRICE SENSITIVE | 245.5KB | Share |
|
PVA Form 4 (Leonard Ross) |
28/12/17 | | 134.49KB | Share |
|
PVA Appendix 3Y - Rogers |
27/12/17 | | 123.14KB | Share |
|
PVA Appendix 3Y - Peterson |
27/12/17 | | 73.08KB | Share |
|
PVA Appendix 3Y - Mazzo |
27/12/17 | | 123.48KB | Share |
|
PVA Appendix 3Y - Lurker |
27/12/17 | | 94.47KB | Share |
|
PVA Appendix 3Y - Godshall |
27/12/17 | | 104.98KB | Share |
|
PVA Appendix 3Y - Duker |
27/12/17 | | 79.92KB | Share |
|
PVA Appendix 3Y - Barry |
27/12/17 | | 93.72KB | Share |
|
PVA Form 4 (Michael Rogers) |
20/12/17 | | 137.35KB | Share |
|
PVA Form 4 (Nancy Lurker) |
20/12/17 | | 102.6KB | Share |
|
PVA Form 4 (James Barry) |
20/12/17 | | 136.62KB | Share |
|
PVA Form 4 (Jay Duker) |
20/12/17 | | 102.03KB | Share |
|
PVA Form 4 (Kristine Peterson) |
20/12/17 | | 99.46KB | Share |
|
PVA Form 4 (Douglas Godshall) |
20/12/17 | | 103.25KB | Share |
|
PVA Form 4 (David Mazzo) |
20/12/17 | | 103.25KB | Share |
|
PVA Form 8-K (Annual Stockholder Meeting Results) |
20/12/17 | | 41.07KB | Share |
|
PVA HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis |
15/12/17 | PRICE SENSITIVE | 526.78KB | Share |
|
PVA Appendix 3B - November 2017 |
05/12/17 | | 365.06KB | Share |
|
PVA Form 14A (Definitive Proxy Statement) |
15/11/17 | | 411.14KB | Share |
|
PVA Form 10-Q - September 30, 2017 |
14/11/17 | PRICE SENSITIVE | 173.5KB | Share |
|
PVA Form 8-K (Q1 FY 2018 Earnings Release) |
08/11/17 | PRICE SENSITIVE | 70.92KB | Share |
|
PVA Appendix 3B - October 2017 |
07/11/17 | | 375.39KB | Share |
|
PVA Schedule 14A (Preliminary Proxy Statement) |
06/11/17 | | 624.84KB | Share |
|
PVA Form 10 - K/A |
01/11/17 | | 270.92KB | Share |
|
PVA pSivida and Nicox Enter Strategic Collaboration Agreement |
12/10/17 | PRICE SENSITIVE | 332.79KB | Share |
|
PVA SEC Grant of Confidential Treatment (Exhibit 10.23 Form 10K) |
12/10/17 | | 8.89KB | Share |
|
PVA Appendix 3B - September 2017 |
04/10/17 | | 377.67KB | Share |
|
PVA pSivida to Present at the Ladenburg Thalmann 2017 Healthcare |
25/09/17 | | 432.85KB | Share |
|
PVA Prospectus Supplement |
21/09/17 | PRICE SENSITIVE | 39.96KB | Share |
|
PVA pSivida Corp FY 2017 Form 10-K as filed for ASX |
14/09/17 | PRICE SENSITIVE | 1.14MB | Share |
|
PVA Form 8-K Earnings Release |
13/09/17 | PRICE SENSITIVE | 72.43KB | Share |
|
PVA Appendix 3B - August 2017 |
07/09/17 | | 369.92KB | Share |
|
PVA Appendix 3B - July 2017 |
03/08/17 | | 371.76KB | Share |
|
PVA Appendix 3B for June 2017 |
12/07/17 | | 373.4KB | Share |
|
PVA EMEA Out License and Amended Global Collaboration Agreement |
11/07/17 | PRICE SENSITIVE | 66.75KB | Share |
|
PVA Form 8K, Appt. of New BoD, Adoption of ST Incentive Plan |
03/07/17 | | 71.46KB | Share |
|
PVA Appendix 3X (Kristine Peterson) |
03/07/17 | | 191.23KB | Share |
|
PVA SEC Form 4 (Debora Jorn) |
30/06/17 | | 143.75KB | Share |
|
PVA SEC Form 4 (Leonard Ross) |
30/06/17 | | 144.14KB | Share |
|
PVA SEC Form 4 (Dario Paggiarino) |
30/06/17 | | 143.73KB | Share |
|
PVA Results of Special Meeting of Shareholders |
30/06/17 | | 37.21KB | Share |
|
PVA Disclosure Document |
26/06/17 | PRICE SENSITIVE | 56.01KB | Share |
|
PVA Disclosure Document |
16/06/17 | PRICE SENSITIVE | | Share |
|
PVA Form 4 - Nancy Lurker |
16/06/17 | | | Share |
|
PVA Appendix 3B |
05/06/17 | | 374.93KB | Share |
|
PVA Definitive Proxy Statement (DEF 14A) |
17/05/17 | | 277.22KB | Share |
|
PVA Disclosure Document |
10/05/17 | PRICE SENSITIVE | 193.2KB | Share |
|
PVA Disclosure Document |
09/05/17 | PRICE SENSITIVE | 381.8KB | Share |
|
PVA Disclosure Document |
05/05/17 | | 43.44KB | Share |
|
PVA Disclosure Document |
05/05/17 | PRICE SENSITIVE | 76.17KB | Share |
|
PVA Disclosure Document |
05/05/17 | | 278.55KB | Share |
|
PVA Appendix 3B |
05/05/17 | | 369.62KB | Share |
|
PVA pSivida Corp. To Report Third Quarter Fiscal Year 2017 Finan |
21/04/17 | | 325.33KB | Share |
|
PVA Appendix 3B |
06/04/17 | | 337.71KB | Share |
|
PVA Abstract on pSivida's Treatment of Posterior Segment Uveitis |
16/03/17 | PRICE SENSITIVE | 528.59KB | Share |
|
PVA Form 8K |
07/03/17 | PRICE SENSITIVE | 102.28KB | Share |
|
PVA Appendix 3B |
03/03/17 | | 336.55KB | Share |
|
PVA Form S-8 Registration Statement |
23/02/17 | | 83.65KB | Share |
|
PVA pSivida to Present at the 2017 BIO CEO & Investor Conference |
13/02/17 | | 318.38KB | Share |
|
PVA Disclosure Document |
10/02/17 | | 799.44KB | Share |
|
PVA Disclosure Document |
09/02/17 | PRICE SENSITIVE | 349.17KB | Share |
|
PVA Disclosure Document |
09/02/17 | PRICE SENSITIVE | 298.06KB | Share |
|
PVA Disclosure Document |
08/02/17 | PRICE SENSITIVE | 189.32KB | Share |
|
PVA Appendix 3B |
06/02/17 | | 339.32KB | Share |
|
PVA Disclosure Document |
03/02/17 | | 299.03KB | Share |
|
PVA Disclosure Document |
27/01/17 | | 446.73KB | Share |
|
PVA Appendix 3B |
06/01/17 | | 337.69KB | Share |
|
PVA Disclosure Document |
03/01/17 | PRICE SENSITIVE | 130.31KB | Share |
|
PVA Disclosure Document |
28/12/16 | | 169.07KB | Share |
|
PVA Disclosure Document |
21/12/16 | | 150.85KB | Share |
|
PVA Form 8-K |
19/12/16 | | 128.04KB | Share |
|
PVA Change of Director's Interest Notice |
15/12/16 | | 96.35KB | Share |
|
PVA Change of Director's Interest Notice |
15/12/16 | | 97.21KB | Share |
|
PVA Change of Director's Interest Notice |
15/12/16 | | 85.61KB | Share |
|
PVA Change of Director's Interest Notice |
15/12/16 | | 65.32KB | Share |